Product Program year 2025 Source: CMS Open Payments

SpeediCath

Device Continence Care

PDI 05708932020404

Open in the dashboard

General payments

$562,943

22,225 payments

Research payments

$0

0 payments

Through program year 2025, $562,943 in general payments and $0 in research payments were reported against SpeediCath (Continence Care).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $33,718 1,475
2024 General $59,096 2,583
2023 General $161,173 6,537
2022 General $165,357 4,373
2021 General $143,599 7,257

Breakdown

Who paid General payments · program years 2021–2025
  1. Coloplast Corp $562,943 22,225 payments
Top recipients General payments · program year 2025
  1. Mary Free Bed Rehab Hospital Teaching hospital · MI $2,500 7% · 1 payment
  2. Magee Rehabilitation Hospital Teaching hospital · PA $1,500 4% · 1 payment
  3. Kailen Gonzalez Physician Assistant, Medical · Fort Myers, FL $465 1% · 9 payments
  4. Yuri Reinberg Pediatric Urology · Jacksonville, FL $421 1% · 7 payments
  5. Mary Wang Nurse Practitioner, Women's Health · Philadelphia, PA $380 1% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $11,468 40% · 356 practitioners
  2. Physician Assistant $3,064 11% · 68 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $2,451 9% · 76 practitioners
  4. Nurse Practitioner $1,774 6% · 44 practitioners
  5. Pediatric Urology Urology $1,452 5% · 26 practitioners

The top 5 of 38 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $8,788 26% · 194 recipients
  2. New York $3,518 10% · 69 recipients
  3. Pennsylvania $3,146 9% · 25 recipients
  4. Michigan $3,014 9% · 19 recipients
  5. New Jersey $1,895 6% · 66 recipients

The top 5 of 42 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

22,225 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record